Skip to Main Content
Table 1

Baseline patient characteristics and GLP-1 plasma measurements of the ICU cohort

ParameterAll PatientsNonsepsisSepsis
N 155 43 112 
Sex, male/female 92/63 25/18 67/45 
Age, years 64 (18–90) 62 (18–85) 66 (20–90) 
APACHE II score 17 (3–40) 14.5 (3–28) 18 (3–40) 
Preexisting diabetes, n (%) 50 (32.3%) 15 (34.9%) 35 (31.3%) 
BMI, kg/m2 25.0 (15.3–61.0) 26.5 (15.9–40.5) 24.9 (15.3–61.0) 
IL-6, pg/mL 141.0 (47.0–518.0) 159.0 (69.7–417.0) 135.0 (47.0–518.0) 
CRP, mg/dL 116.5 (5–230) 13 (5–230) 165 (5–230) 
Glucose, mg/dL 141.0 (47.0–518.0) 159.0 (69.7–417.0) 135.0 (47.0–518.0) 
Insulin, mU/L 8.1 (0.2–1,000) 32.0 (1.0–1,000) 5.2 (0.2–438) 
GLP-1, pmol/L 97 (14.4–303.5) 67.5 (17.2–303.5) 101.1 (14.4–286.5) 
ParameterAll PatientsNonsepsisSepsis
N 155 43 112 
Sex, male/female 92/63 25/18 67/45 
Age, years 64 (18–90) 62 (18–85) 66 (20–90) 
APACHE II score 17 (3–40) 14.5 (3–28) 18 (3–40) 
Preexisting diabetes, n (%) 50 (32.3%) 15 (34.9%) 35 (31.3%) 
BMI, kg/m2 25.0 (15.3–61.0) 26.5 (15.9–40.5) 24.9 (15.3–61.0) 
IL-6, pg/mL 141.0 (47.0–518.0) 159.0 (69.7–417.0) 135.0 (47.0–518.0) 
CRP, mg/dL 116.5 (5–230) 13 (5–230) 165 (5–230) 
Glucose, mg/dL 141.0 (47.0–518.0) 159.0 (69.7–417.0) 135.0 (47.0–518.0) 
Insulin, mU/L 8.1 (0.2–1,000) 32.0 (1.0–1,000) 5.2 (0.2–438) 
GLP-1, pmol/L 97 (14.4–303.5) 67.5 (17.2–303.5) 101.1 (14.4–286.5) 

For quantitative variables, median (range) are given.

Close Modal

or Create an Account

Close Modal
Close Modal